Rhythm Pharmaceuticals
RYTM
RYTM
143 hedge funds and large institutions have $1.56B invested in Rhythm Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
23% more funds holding
Funds holding: 116 → 143 (+27)
23% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 39
3.29% more ownership
Funds ownership: 116.45% → 119.74% (+3.3%)
Holders
143
Holding in Top 10
7
Calls
$10.9M
Puts
$1.32M
Top Buyers
| 1 | +$47.6M | |
| 2 | +$13.4M | |
| 3 | +$9.17M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$8.73M |
| 5 |
Morgan Stanley
New York
|
+$7.64M |
Top Sellers
| 1 | -$35.5M | |
| 2 | -$20.7M | |
| 3 | -$13.9M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$12.7M |
| 5 |
Walleye Capital
New York
|
-$6.52M |